Latest Breaking News On - Didier laurens - Page 1 : vimarsana.com

Advicenne Announces the Approval of All Resolutions Supported by the Board of Directors at Its Combined General Meeting

Advicenne: Strong improvement of 2023 results thanks to sustained commercial activity on Sibnayal® -March 28, 2024 at 02:31 am EDT

Advicenne: Strong improvement of 2023 results thanks to sustained commercial activity on Sibnayal

Advicenne: FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.

Advicenne: ODD designation in cystinuria -March 25, 2024 at 03:21 am EDT

Biopharmaceutical company Advicenne announces that ADV7103, its proprietary drug, has been granted orphan drug status by the US FDA for the treatment of cystinuria in the USA.Cystinuria is a genetic...

Advicenne : Inside Information / Other news releases -March 25, 2024 at 04:13 am EDT

FDA grants Orphan Drug Designation to ADV7103 for the treatment of cystinuria. • After distal Renal Tubular Acidosis in December 2022,...

FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.

Advicenne Reports 2023 Gross Sales1 up 20% to €4.43 Million

Advicenne Announces Its 2024 Financial Calendar

Advicenne Announces Its 2024 Financial Calendar